Yescarta Becomes Japan’s Second Approved CAR-T
Other Nods For Alunbrig, Calquence, Emgality
Japan's latest batch of new drug approvals includes the country's second CAR-T therapy, along with multiple oncology drugs and a novel migraine treatments, which should all reach the market in the next few months following reimbursement price listing.
